What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Taconic, Cyagen Announce Partnership

To provide access to premium custom model design and generation services

Taconic Biosciences and Cyagen Biosciences have announced a strategic partnership. Under the agreement terms, the two companies will combine resources to provide the global scientific community with access to premium custom model design and generation services backed by comprehensive capabilities and cutting-edge, fully-licensed technologies.

Taconic is recognized for creating complex genetically engineered mice and rats for biomedical research. Cyagen entered the industry in 2005 and has gained a strong following for providing model and vector generation services. Through the alliance, Cyagen customers gain access to expanded expertise, comprehensive program management, state-of-the art technologies, pricing flexibility, and faster project timelines through a single point of contact, ensuring the best solution for each unique project. 

“Taconic will provide the best solution to every model generation customer through access to scientific experts who generate superior designs using state-of-the-art methods.  Through this alliance with Cyagen, Taconic can now offer customers the broadest range of options in the industry in line with market demand,” shared Dr. Robert Rosenthal, chief executive officer of Taconic Biosciences.
 
“Cyagen Biosciences provides researchers with the highest quality animal models possible to ensure ground breaking discoveries.  Researchers are increasingly demanding higher quality animal model services at lower costs. Through this new alliance with Taconic, Cyagen will offer researchers even higher quality animal models, with new options available to minimize or eliminate quarantine and other added costs, while providing production capabilities that exceed previous standards and expectations,” commented Dr. Reza Rezaei, vice president of Sales of Cyagen Biosciences.
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics